Ignite Creation Date:
2024-05-06 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 12:44 PM
Study NCT ID:
NCT03505008
Status:
UNKNOWN
Last Update Posted:
2021-09-01
First Post:
2018-04-16
Brief Title:
Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan South Korea and Taiwan
Sponsor:
Keio University
Organization:
Keio University
Organization Data
Organization:
Keio University
Class:
OTHER
Study ID:
D2E7-C000-401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Keio University
Lead Sponsor Class:
OTHER
Responsible Party:
Yuko Kaneko
Responsible Party Title:
Study Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Keio University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eisai Co Ltd | INDUSTRY |